Results for tag: "Doxercalciferol"

Doxercalciferol is a synthetic form of vitamin D used to treat endocrine and metabolic disorders. It is used to treat secondary hyperparathyroidism, a condition caused by chronic kidney disease, and to treat hypoparathyroidism, a condition caused by low levels of parathyroid hormone. Doxercalciferol is also used to treat vitamin D deficiency and to prevent bone loss in people with osteoporosis. It is available in both oral and injectable forms. Doxercalciferol is a relatively new drug, and its use is increasing as more people are diagnosed with endocrine and metabolic disorders. It is generally well-tolerated and has few side effects. It is also cost-effective, making it an attractive option for many patients. Companies in the Doxercalciferol market include AbbVie, Amgen, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Sanofi. Show Less Read more